Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.45T | 2.38T | 2.27T | 2.10T | 2.01T | 1.91T | Gross Profit |
622.30B | 593.13B | 526.68B | 450.44B | 397.92B | 469.74B | EBIT |
430.38B | 339.69B | 305.40B | 244.98B | 203.77B | 280.62B | EBITDA |
496.38B | 473.42B | 430.70B | 356.48B | 301.97B | 372.05B | Net Income Common Stockholders |
203.81B | 224.65B | 197.00B | 176.99B | 129.58B | 183.97B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
181.90B | 189.81B | 144.26B | 156.23B | 199.64B | 190.31B | Total Assets |
6.80T | 9.49T | 8.84T | 8.21T | 7.74T | 7.40T | Total Debt |
2.91T | 4.43T | 4.05T | 3.67T | 3.62T | 3.48T | Net Debt |
2.73T | 4.25T | 3.91T | 3.52T | 3.43T | 3.30T | Total Liabilities |
4.38T | 6.25T | 5.81T | 5.29T | 5.09T | 4.91T | Stockholders Equity |
2.34T | 3.11T | 2.90T | 2.80T | 2.56T | 2.41T |
Cash Flow | Free Cash Flow | ||||
134.85B | 20.86B | -65.04B | 29.90B | -88.47B | -386.72B | Operating Cash Flow |
134.85B | 241.70B | 297.71B | 271.47B | 187.86B | 87.09B | Investing Cash Flow |
0.00 | -286.99B | -422.03B | -210.06B | -131.03B | -532.81B | Financing Cash Flow |
0.00 | 59.99B | 111.45B | -139.60B | -66.56B | 467.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $28.92B | 25.30 | 9.67% | 3.31% | 5.61% | 19.66% | |
75 Outperform | $26.60B | 27.31 | 9.01% | 3.92% | 3.91% | 8.78% | |
75 Outperform | $26.13B | 16.12 | 7.82% | 1.52% | -6.74% | -13.89% | |
66 Neutral | $13.61B | 114.91 | 3.40% | 4.11% | 2.35% | -73.89% | |
63 Neutral | $18.61B | 26.71 | 12.09% | 3.50% | 7.61% | 27.83% | |
61 Neutral | $2.85B | 10.96 | 0.41% | 8438.88% | 5.73% | -21.25% | |
57 Neutral | $18.00B | 31.20 | 9.37% | 3.95% | 1.55% | 0.73% |